SG11201709800RA - Composition for inhibiting and preventing myopathy, containing bean leaf extract as active ingredient - Google Patents

Composition for inhibiting and preventing myopathy, containing bean leaf extract as active ingredient

Info

Publication number
SG11201709800RA
SG11201709800RA SG11201709800RA SG11201709800RA SG11201709800RA SG 11201709800R A SG11201709800R A SG 11201709800RA SG 11201709800R A SG11201709800R A SG 11201709800RA SG 11201709800R A SG11201709800R A SG 11201709800RA SG 11201709800R A SG11201709800R A SG 11201709800RA
Authority
SG
Singapore
Prior art keywords
inhibiting
composition
active ingredient
leaf extract
bean leaf
Prior art date
Application number
SG11201709800RA
Inventor
Byung Gyu Kim
Young-Gyu Kang
Soo Hyun Kim
Chan Woong Park
Hee Young Jeon
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of SG11201709800RA publication Critical patent/SG11201709800RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
SG11201709800RA 2015-06-30 2016-05-09 Composition for inhibiting and preventing myopathy, containing bean leaf extract as active ingredient SG11201709800RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150092701A KR20170002846A (en) 2015-06-30 2015-06-30 Composition containing extract of soybean leaves for suppressing and preventing myopathy
PCT/KR2016/004828 WO2017003086A1 (en) 2015-06-30 2016-05-09 Composition for inhibiting and preventing myopathy, containing bean leaf extract as active ingredient

Publications (1)

Publication Number Publication Date
SG11201709800RA true SG11201709800RA (en) 2017-12-28

Family

ID=57607808

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201709800RA SG11201709800RA (en) 2015-06-30 2016-05-09 Composition for inhibiting and preventing myopathy, containing bean leaf extract as active ingredient

Country Status (6)

Country Link
US (2) US20180169166A1 (en)
JP (1) JP2018519274A (en)
KR (1) KR20170002846A (en)
CN (1) CN108112234B (en)
SG (1) SG11201709800RA (en)
WO (1) WO2017003086A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019520319A (en) 2016-05-02 2019-07-18 ニュートゥリー カンパニー リミテッド Composition for improving muscle function or exercise performance including azuki bean
WO2017192013A1 (en) * 2016-05-02 2017-11-09 연세대학교 산학협력단 Composition for improving muscular function or for enhancing exercise performance comprising vigna angularis var. angularis
KR20190075263A (en) 2017-12-21 2019-07-01 주식회사 메타스크린 Roasting tea from soybean leaf with high content of isoflavone
BR112022002727A2 (en) * 2019-08-20 2022-08-23 Nuritas Ltd PEPTIDES FOR TREATMENT OF MUSCULAR ATROPHY

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040047927A1 (en) 2002-09-05 2004-03-11 Yaguang Liu Soybean drug and new method of extracting soybean isoflavone
KR20060066564A (en) 2004-12-13 2006-06-16 김민경 Manufacturing method of pure, pollution-free functional (muscle mineral) beverage using germinated food
JP2007063135A (en) 2005-08-29 2007-03-15 Nikko Chemical Co Ltd Ameliorating agent for muscle fatigue
KR101182358B1 (en) * 2006-06-07 2012-09-11 허베이 이링 메디슨 리서치 인스티튜트 코오포레이션 리미티드 A medicine composition for treating muscular atrophy and myasthenia gravis and method of preparing the same
CA2674787C (en) * 2007-01-08 2014-02-11 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food Plant compositions enriched in dehydrosoyasaponin i (d-i) and methods of producing such compositions
KR101034596B1 (en) * 2009-05-07 2011-05-12 원광대학교산학협력단 A composition for improving and delaying symptoms such as muscule weakness, amyotrophy, articulation disorder, dysphagia
WO2011043827A1 (en) 2009-10-09 2011-04-14 Nestec S.A. Methods for preventing or treating sarcopenia and muscle atrophy in animals
WO2011122872A2 (en) 2010-03-31 2011-10-06 (주)아모레퍼시픽 Composition comprising coumestrol or a bean extract containing coumestrol
KR20120022085A (en) 2010-08-25 2012-03-12 주식회사 인섹트 바이오텍 Formulations for prevention or treatment of obesity, hyperlipidemia, atherosclerosis, fatty liver, diabetes mellitus or metabolic syndrome comprising extracts of glycine max leaves as an active ingredient
US20120225054A1 (en) * 2011-03-02 2012-09-06 Herbal Bon Biotech Inc. Use of legume extracts for inducing and enhancing autophagy and apoptosis and for preventing and/or treating cancers
CN102600316B (en) * 2012-02-06 2013-12-11 杨家驥 Chinese medicinal herb preparation for treating closed injury and preparation method thereof
KR102076001B1 (en) * 2012-09-10 2020-02-12 (주)아모레퍼시픽 Composition for antiinflammation containing extract of soybean leaf
KR102200014B1 (en) 2013-05-06 2021-01-08 (주)아모레퍼시픽 Composition for preventing and treating climacteric symptoms comprising extract of bean containing coumestrol
KR101439783B1 (en) * 2013-07-18 2014-09-12 동의대학교 산학협력단 Maximowiczia Chinensis Extracts For Preventing, Treating Muscular Dystrophy And Manufacturing Method of thereof
US9701977B2 (en) * 2013-11-19 2017-07-11 Wisconsin Alumni Research Foundation Prephenate dehydrogenases and arogenate dehydrogenases that are insensitive to effector feedback inhibition and methods of using the same
CN106176837B (en) * 2016-08-15 2020-02-21 江苏红豆杉药业有限公司 Pharmaceutical composition, preparation method and application thereof

Also Published As

Publication number Publication date
US20200000867A1 (en) 2020-01-02
CN108112234B (en) 2021-08-17
WO2017003086A1 (en) 2017-01-05
JP2018519274A (en) 2018-07-19
US20180169166A1 (en) 2018-06-21
CN108112234A (en) 2018-06-01
US10898535B2 (en) 2021-01-26
KR20170002846A (en) 2017-01-09

Similar Documents

Publication Publication Date Title
IL254714A0 (en) Quinoline derivatives, and pharmaceutical compositions containing them
IL247062A0 (en) Heterocyclic compounds , their preparation and compositions pharmaceutical containing them
HK1243999A1 (en) Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use
EP3159338A4 (en) Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredient
PT3235494T (en) Transdermal preparation containing donepezil as active ingredient
ZA201605379B (en) Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient
SG11201605868XA (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
SG11201709800RA (en) Composition for inhibiting and preventing myopathy, containing bean leaf extract as active ingredient
HK1243927A1 (en) Composition containing theasapogenol derivative as active ingredient
IL258977B (en) Pyperidyl derivatives, their preparation and pharmaceutical compositions containing them
EP3295946A4 (en) Composition, containing lithospermi radix extract as active ingredient, for preventing, alleviating, or treating peripheral neuropathy
SG11201610636VA (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
IL251456A0 (en) Compound having gpr119 agonistic activity, method for preparing the same, and pharmaceutical composition including the same as effective component
EP2982378A4 (en) Composition for preventing or treating sepsis or septic shock, comprising adk protein as active ingredient
EP3205345A4 (en) Composition for hair loss prevention or hair growth stimulation comprising artemisia umbelliformis extract
EP3144005A4 (en) Composition for preventing and treating male infertility, containing mixed herbal extract as active ingredient and use thereof
EP3284464A4 (en) Composition for preventing and treating pancreatitis containing naphthoquinone-based compound as active ingredient
GB2579480B (en) Composition for preventing or treating cancer containing Triazolopyridine-based derivative as active ingredient
EP3552606A4 (en) Composition for preventing or treating diseases caused by caffeine abuse including euodia extract or evodiamine as active ingredient
SG11201807498TA (en) Flavor modulator containing 4-alkoxycinnamaldehyde derivative as active ingredient
IL273738A (en) Method for preparing cell extract component or composition exhibiting cytocidal activity
EP3443975A4 (en) Pharmaceutical composition for preventing or treating hearing loss comprising oat extract as an active ingredient
PL3216452T3 (en) Composition for preventing or treating mucositis comprising necrox as effective ingredient
IL259900A (en) Aminoazole derivatives, compositions containing same and uses thereof
HK1213812A1 (en) M10c1 compound and active ingredient-containing composition and preparation method thereof m10c1